Read the full press release on the Nucleome Therapeutics website: https://nucleome.com/news-publications/news-nucleome-raises-oversubscribed-series-a/
Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing
19 October 2022
The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.
©
Shutterstock/sciencepics